A group of immune cells that normally protect against inflammation in the gastrointestinal tract may have the opposite effect in multiple sclerosis (MS) and other brain inflammation-related conditions, according to a new study. The results suggest that countering the activity of these cells could be a new therapeutic approach for such conditions.
